ISPE President/CEO Announces Retirement

International Society for Pharmaceutical Engineering (ISPE) President and CEO Thomas B. Hartman has announced his retirement from ISPE in early fall 2024. He will stay on until early fall to ensure a smooth transition.

Hartman has served ISPE with unparalleled dedication and leadership for four years, guiding the nonprofit through significant milestones and achievements. Under his direction, ISPE has flourished, expanding its presence in the pharmaceutical industry to over 22,000 members and enhancing its reputation as a thought leader in shaping the future of the pharmaceutical industry.

Prior to this role at ISPE, Hartman was vice president of GMP Operations, Biopharmaceutical Development & Supply for GSK.

"I joined ISPE as president and CEO, following my initial plans for retirement after a long and fulfilling career in the pharmaceutical industry. I look forward to supporting ISPE through this transition and to my retirement. I thank the ISPE International Board, staff, and membership for their support and for what we have accomplished together over the past four years and have full confidence that the vibrant ISPE community will continue to thrive.

Prior to taking on the role of president and CEO of ISPE, Hartman had served for nearly seven years on ISPE’s International Board of Directors. He has been a member of ISPE since 2001.

A search committee has been formed for a new CEO.